Exicure, Inc. (XCUR) Dividend History

Exicure, Inc. (XCUR) is a biotechnology company focused on developing innovative nucleic acid therapeutics using its proprietary spherical nucleic acid (SNA) technology. The company aims to address challenging genetic and inflammatory diseases with its platform, which facilitates targeted gene regulation and modulation. Based in Chicago, Exicure leverages its scientific expertise to advance therapies in areas such as oncology, dermatology, and immunology.

2430 N. Halsted St., Chicago, IL, 60614
Phone: 847-673-1700
Website: https://www.exicuretx.com

Dividend History

Exicure, Inc. currently does not pay dividends

Company News

  • Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results. FMC posted adjusted earnings of $1.07 per share, missing market estimates of $1.08 per share. The company’s quarterly sales came in at $1.15 billion versus expectations of $1.25 billion. FMC shares dipped 9.8% to $54.51 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) jumped 144.4% to $0.5427 after dipping around 26% on Monday. Tenax Therapeutics, Inc. (NASDAQ: TENX) jumped 96% to $17.13 after the company announced the USPTO granted notice of allowance for the U.S. patent application "Levosimendan For Treating Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction." Agrify Corporation (NASDAQ: AGFY) shares climbed 70.1% to $1.0889. Agrify achieved milestone with PX-30 hydrocarbon extraction system installation in Michigan Facility. ADDvantage Technologies Group, Inc. (NASDAQ: AEY) gained 36% to $0.4769. Palantir Technologies Inc. (NYSE: PLTR) shares surged 27% to $21.23 after the company reported better-than-expected fourth-quarter sales results and issued guidance. Zenvia Inc. (NASDAQ: ZENV) rose 25% to $1.4621. Zenvia announced agreements to address funding gap and introduced EBITDA guidance for 2024, with a range between BRL 120 million and BRL140 million. Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 24% to $8.80. Helius Medical Technologies announced alignment with the FDA on registrational program for treatment of stroke patients. Exicure, Inc. (NASDAQ: XCUR) gained 21.7% to $0.67 after the company announced it entered ...

    Benzinga
  • Insiders are buying these penny stocks but are they worth the risk? The post Penny Stocks To Buy: 6 Insider Picks Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AKBA SOFI VNRX XFOR
  • Exicure, Inc. (XCUR) delivered earnings and revenue surprises of -68.75% and 559.63%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
Page data last updated 07/23/2025 22:10:19 UTC